Skip to content
Home/Companies/Healthcare/Synapse Medicine
SM

Synapse Medicine

Healthcare·France·Active·4yr hold

Synapse Medicine is a healthtech company, headquartered in France.

Entry
2022
Hold
4yr
Status
Active
Est. EV
–

Who owns Synapse Medicine?

Synapse Medicine is currently owned by Korelya Capital through K-Fund II (2021 vintage), since 2022. Across its history, Synapse Medicine has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

Korelya Capital
Most recent investor
Korelya Capital
K-Fund II · 2021 · VC
2 ownership periods · full history below

Key facts

HQFrance
SectorHealthtech

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by XAnge and Korelya Capital since 2018.
Co-invest · 2 holders · 2018 · present
XAnge
XAngeActive
2018 · present · Digital 3 · 2017 · VC
MOIC
–
Korelya Capital
Korelya CapitalActive
2022 · present · K-Fund II · 2021 · VC
MOIC
–

More from K-Fund II

Other portfolio companies in the same fund.

DeepIP
Active
AI/MLFrance· 2026
Gradium
Active
AI/MLFrance· 2025
Junction
Active
SoftwareSweden· 2025
ifeel
Active
HealthcareSpain· 2024
Mistral AI
Active
SoftwareFrance· 2024
My Real Trip
Active
ConsumerSouth Korea· 2024

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
Active
Advent InternationalUS
Data refreshed weekly · Sourced from public filings